Exact Sciences, US30063P1057

Exact Sciences stock heads into the open after a recent Nasdaq gain

Published on 09/21/2026 at 07:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 18, 2026, Exact Sciences stock ended higher on the Nasdaq, with trading volume picking up compared with earlier in the week. Today, investors watch Exact Sciences stock ahead of the open for company and sector cues.

Wissenschaftlerinnen analysieren Krebsproben in einem modernen Diagnostiklabor von Exact Sciences
Exact Sciences Corp. betreibt hochmoderne Labore für die molekulare Krebsfrüherkennung weltweit ISIN US30063P1057, Illustration mit AI erstellt.

Exact Sciences stock closed higher on the Nasdaq on September 18, 2026, with the regular-session close marking a positive move versus the prior day in USD terms. The advance came as broader US equity benchmarks also ended the day with modest gains, providing a supportive backdrop for the shares.

September 18, 2026 in numbers

Exact Sciences Corp. (ISIN US30063P1057, Nasdaq: EXAS) saw its shares trade through a discernible intraday range on the Nasdaq on September 18, 2026, with the close sitting between the day low and day high in line with normal trading dynamics. The stock finished the session up by a clear percent figure compared with the previous Nasdaq close, while its trading volume on September 18, 2026 exceeded levels seen earlier in the week, signaling increased activity around the name. In the same session, a major US equity index such as the Nasdaq Composite also posted a percentage gain, underscoring that the move in Exact Sciences shares occurred against a generally constructive market backdrop.

Outlook for today

Today, September 21, 2026, Exact Sciences heads into the US open without a newly reported company-specific event in the early morning that would redefine the short-term narrative for the shares. In the coming sessions, scheduled sector and market data, including healthcare-related news flow and broader US economic releases, can influence sentiment toward Exact Sciences by affecting expectations for diagnostic demand and reimbursement trends. Against this backdrop, investors will assess how Exact Sciences trades today relative to its recent September 18, 2026 performance and to moves in the wider market.

Disclaimer...

en | US30063P1057 | EXACT SCIENCES | boerse | 70141942 | bgmi